The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 4, 2007, Pages 402-408

  Nagy, Zsuzsanna ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Alzheimer's disease; Cell cycle; Cyclin dependent kinase; cyclin dependent kinase inhibitor

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; EVIDENCE BASED MEDICINE; HUMAN; MITOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AGE OF ONSET; ALZHEIMER DISEASE; BRAIN; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HOMEOSTASIS; HUMANS; VARIATION (GENETICS);

EID: 33947138841     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.11.001     Document Type: Review

References (50)

1. Lanctot K.L., Herrmann N., Yau K.K., Khan L.R., Liu B.A., LouLouand M.M., and Einarson T.R. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ 169 (2003) 557-564
2. Williams B.R., Nazariansand A., and Gill M.A. A review of rivastigmine: a reversible cholinesterase inhibitor. Clin. Ther. 25 (2003) 1634-1653
3. Nagy Z., Hindley N.J., Braak H., Braak E., Yilmazer-Hanke D.M., Schultz C., Barnetson L., Jobstand K.A., and Smith A.D. Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study. Dement. Geriatr. Cogn. Disord. 10 (1999) 109-114
4. Mayeux R. Biomarkers: potential uses and limitations. NeuroRx 1 (2004) 182-188
5. Nagy Z., Esiri M.M., Hindley N.J., Joachim C., Morris J.H., King E.M.-F., McDonald B., Litchfield S., Barnetson L., Jobstand K.A., and Smith A.D. Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dementia 9 (1998) 219-226
6. Irizarry M.C. Biomarkers of Alzheimer disease in plasma. NeuroRx 1 (2004) 226-234
7. Blennow K. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment. Expert Rev. Mol. Diagn. 5 (2005) 661-672
8. Dickersonand B.C., and Sperling R.A. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx 2 (2005) 348-360
9. Nagy Z., Esiriand M.M., and Smith A.D. The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience 84 (1998) 731-739
10. Gartner U., Holzer M., Heumannand R., and Arendt T. Induction of p21ras in Alzheimer pathology. NeuroReport 6 (1995) 1441-1444
11. Arendt T., Holzerand M., and Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J. Neural Transm. 105 (1998) 949-960
12. Nagy Z., Esiri M.M., Catoand A.M., and Smith A.D. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. (Berl.) 94 (1997) 6-15
13. Nagyand Z., and Esiri M.M. Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy. Exp. Neurol-Neurodegener. 150 (1998) 240-247
14. Vincent I., Jicha G., Rosadoand M., and Dickson D.W. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17 (1997) 3588-3598
15. Arendt T. Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog. Neurobiol. 71 (2003) 83-248
16. Yang Y., Geldmacherand D.S., and Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21 (2001) 2661-2668
17. Suzuki T., Oishi M., Marshak D.R., Czernik A.J., Nairnand A.C., and Greengard P. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 13 (1994) 1114-1122
18. Baumann K., Mandelkow E.M., Biernat J., Piwnica Wormsand H., and Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 336 (1993) 417-424
19. Nagy Z., Smith M.Z., Esiri M.M., Barnetsonand L., and Smith A.D. Hyperhomocysteinemia in Alzheimer's disease and expression of cell cycle markers in brain. JNNP 69 (2000) 565-566
20. Casadesus G., Garrett M.R., Webber K.M., Hartzler A.W., Atwood C.S., Perry G., Bowenand R.L., and Smith M.A. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease. Drugs R&D 7 (2006) 187-193
21. Casadesus G., Atwood C.S., Zhu X., Hartzler A.W., Webber K.M., Perry G., Bowenand R.L., and Smith M.A. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell. Mol. Life Sci. 62 (2005) 293-298
22. Lustig R.H. Sex hormone modulation of neural development in vitro. Horm. Behav. 28 (1994) 383-395
23. Mussa G.C., Mussa F., Bretto R., Zambelliand M.C., and Silvestro L. Influence of thyroid in nervous system growth. Minerva Pediatr. 53 (2001) 325-353
24. Langleyand B., and Ratan R.R. Oxidative stress-induced death in the nervous system: cell cycle dependent or independent?. J. Neurosci. Res. 77 (2004) 621-629
25. Kleinand J.A., and Ackerman S.L. Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest. 111 (2003) 785-793
26. Arendt T., Schindler C., Bruckner M.K., Eschrich K., Bigl V., Zedlickand D., and Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J. Neurosci. Off. J. Soc. Neurosci. 17 (1997) 516-529
27. Zhu X., Raina A., Perryand G., and Smith M. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol. 3 (2004) 219-226
28. Nagy Z. Cell cycle regulatory failure in neurones: causes and consequences. Neurobiol. Aging 21 (2000) 761-769
29. Nagy Z. The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease. J. Cell. Mol. Med. 9 (2005) 531-541
30. Chang B.D., Watanabe K., Broude E.V., Fang J., Poole J.C., Kalinichenkoand T.V., and Roninson I.B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4291-4296
31. Ogawa O., Lee H.G., Zhu X., Raina A., Harris P.L., Castellani R.J., Perryand G., and Smith M.A. Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2 (2003) 105-110
32. Zhu X., McShea A., Harris P.L., Raina A.K., Castellani R.J., Funk J.O., Shah S., Atwood C., Bowen R., Bowser R., Morelli L., Perryand G., and Smith M.A. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J. Neurosci. Res. 75 (2004) 698-703
33. Raina A.K., Hochman A., Zhu X., Rottkamp C.A., Nunomura A., Siedlak S.L., Boux H., Castellani R.J., Perryand G., and Smith M.A. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol. (Berl.) 101 (2001) 305-310
34. Burke W.J., McLaughlin J.R., Chung H.D., Gillespie K.N., Grossberg G.T., Luqueand F.A., and Zimmerman J. Occurrence of cancer in Alzheimer and elderly control patients: an epidemiologic necropsy study. Alzheimer Dis. Assoc. Disord. 8 (1994) 22-28
35. Stieler J.T., Lederer C., Bruckner M.K., Wolf H., Holzer M., Gertzand H.J., and Arendt T. Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. NeuroReport 12 (2001) 3969-3972
36. Urcelay E., Ibarreta D., Parrilla R., Ayusoand M.S., and Martin-Requero A. Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the na+/H+ exchanger. Neurobiol. Dis. 8 (2001) 289-298
37. Tatebayashi Y., Takeda M., Kashiwagi Y., Okochi M., Kurumadani T., Sekiyama A., Kanayama G., Hariguchiand S., and Nishimura T. Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease. Dementia 6 (1995) 9-16
38. Khanand T.K., and Alkon D.L. An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13203-13207
39. Nagy Z., Combrinck M., Budgeand M., and McShane R. Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease. Neurosci. Lett. 317 (2002) 81-84
40. Mousses S., Ozcelik H., Lee P.D., Malkin D., Bulland S.B., and Andrulis I.L. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum. Mol. Genet. 4 (1995) 1089-1092
41. Chedid M., Michieli P., Lengel C., Huppiand K., and Givol D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene 9 (1994) 3021-3024
42. Sjalander A., Birgander R., Rannug A., Alexandrie A.K., Tornlingand G., and Beckman G. Association between the p21 codon 31 A1 (arg) allele and lung cancer. Hum. Hered. 46 (1996) 221-225
43. Garcia J., Ahmadi A., Wonnacott A., Sutcliffe W., Nagga K., Soderkvistand P., and Marcusson J. Association of Insulin-Like Growth Factor-1 Receptor Polymorphism in Dementia. Dement. Geriatr. Cogn. Disord. 22 (2006) 439-444
44. P.D. Sundar, E. Feingold, R.L. Minster, S.T. Dekoskyand, M.I. Kamboh, Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol. Aging (in press) (Electronic publication ahead of print). doi:10.1016/j.neurobiolaging.2006.04.005.
45. Pirskanen M., Hiltunen M., Mannermaa A., Helisalmi S., Lehtovirta M., Hanninenand T., and Soininen H. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur. J. Hum. Genet. 13 (2005) 1000-1006
46. Kibel A.S., Suarez B.K., Belani J., Oh J., Webster R., Brophy-Ebbers M., Guo C., Catalona W.J., Picusand J., and Goodfellow P.J. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Cancer Res. 63 (2003) 2033-2036
47. de las Cuevas N., Munoz U., Hermidaand O.G., and Martin-Requero A. Altered transcriptional regulators in response to serum in immortalized lymphocytes from Alzheimer's disease patients. Neurobiol. Aging 26 (2005) 615-624
48. Uberti D., Carsana T., Bernardi E., Rodella L., Grigolato P., Lanni C., Racchi M., Govoniand S., and Memo M. Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients. J. Cell Sci. 115 (2002) 3131-3138
49. Dixonand B.S., and Dennis M.J. Regulation of mitogenesis by kinins in arterial smooth muscle cells. Am. J. Physiol. 273 (1997) C7-C20
50. Dixon B.S., Evanoff D., Fangand W.B., and Dennis M.J. Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1. Am. J. Physiol.: Cell Physiol. 283 (2002) C193-C203